计划性CD34+干细胞增强能否预防外周血单倍体造血移植后移植物功能不良？ - Suppr

Suppr

超能文献

Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?

作者信息

Abboud Ramzi, Slade Michael, Abboud Camille, DiPersio John F

机构信息

Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.

出版信息

Leuk Lymphoma. 2021 Mar;62(3):749-751. doi: 10.1080/10428194.2020.1839657. Epub 2020 Nov 2.

DOI:10.1080/10428194.2020.1839657

PMID:33135522

Abstract

摘要

相似文献

Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?

Leuk Lymphoma. 2021 Mar;62(3):749-751. doi: 10.1080/10428194.2020.1839657. Epub 2020 Nov 2.

Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.

J Cancer Res Clin Oncol. 2015 Dec;141(12):2241-51. doi: 10.1007/s00432-015-2027-x. Epub 2015 Aug 14.

Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.

Crit Rev Oncol Hematol. 2019 Jan;133:120-128. doi: 10.1016/j.critrevonc.2018.05.017. Epub 2018 Jun 11.

Pre-infusion single-dose mesenchymal stem cells promote platelet engraftment and decrease severe acute graft versus host disease without relapse in haploidentical peripheral blood stem cell transplantation.

J Int Med Res. 2020 May;48(5):300060520920438. doi: 10.1177/0300060520920438.

Ex Vivo CD34-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.

Biol Blood Marrow Transplant. 2017 Mar;23(3):452-458. doi: 10.1016/j.bbmt.2016.12.633. Epub 2016 Dec 23.

Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Haematologica. 2017 Feb;102(2):224-234. doi: 10.3324/haematol.2016.148510. Epub 2016 Dec 7.

CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation.

Leuk Lymphoma. 2003 Sep;44(9):1509-13. doi: 10.1080/1042819031000083019.

Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2056-2064. doi: 10.1016/j.bbmt.2016.08.006. Epub 2016 Aug 9.

Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia.

Blood. 2010 Feb 11;115(6):1296-302. doi: 10.1182/blood-2009-05-218982. Epub 2009 Nov 6.

Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.

Haematologica. 2006 Jul;91(7):935-40.

引用本文的文献

[Selected donor CD34(+) cell boosts for salvage treatment of poor graft function following allogeneic hematopoietic stem cell transplantation in primary myelofibrosis: 3 cases report].

Zhonghua Xue Ye Xue Za Zhi. 2024 Aug 14;45(8):785-788. doi: 10.3760/cma.j.cn121090-20240117-00029.

Janus kinase inhibition in the treatment and prevention of graft-versus-host disease.

Front Immunol. 2024 Feb 6;15:1304065. doi: 10.3389/fimmu.2024.1304065. eCollection 2024.

Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation.

Ther Adv Hematol. 2020 Aug 17;11:2040620720948743. doi: 10.1177/2040620720948743. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验